Cargando…

Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status

To evaluate and compare the performance of synthetic magnetic resonance imaging (SyMRI) in classifying benign and malignant breast lesions and predicting the expression status of immunohistochemistry (IHC) markers. We retrospectively analysed 121 patients with breast lesions who underwent dynamic co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiaojun, Fan, Zhichang, Jiang, Hongnan, Niu, Jinliang, Bian, Wenjin, Wang, Chen, Wang, Ying, Zhang, Runmei, Zhang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589282/ https://www.ncbi.nlm.nih.gov/pubmed/37864025 http://dx.doi.org/10.1038/s41598-023-45079-2

Ejemplares similares

Evaluation of the differentiation of benign and malignant breast lesions using synthetic relaxometry and the Kaiser score
por: Meng, Lingsong, et al.
Publicado: (2022)

Immunohistochemical expression of interleukin-17 and hormonal receptors in benign and malignant breast lesions
por: Ali, Eman Taha, et al.
Publicado: (2020)

MRI-Based Machine Learning in Differentiation Between Benign and Malignant Breast Lesions
por: Zhao, Yanjie, et al.
Publicado: (2021)

Differentiating Benign from Malignant Sinonasal Lesions: Feasibility of Diffusion Weighted MRI
por: El-Gerby, Khaled M., et al.
Publicado: (2017)

Role of diffusion MRI in characterizing benign and malignant breast lesions
por: Palle, Lalitha, et al.
Publicado: (2009)

Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study)
por: Gabal, Samia Mohamed, et al.
Publicado: (2018)

Synthetic MRI plus FSE-PROPELLER DWI for differentiating malignant from benign head and neck tumors: a preliminary study
por: Wen, Baohong, et al.
Publicado: (2023)

Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions
por: Ahmed, Eiman Siddig, et al.
Publicado: (2020)

Differentiation of Benign and Malignant Breast Lesions Using ADC Values and ADC Ratio in Breast MRI
por: Tsvetkova, Silvia, et al.
Publicado: (2022)

Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions
por: Parente, Paola, et al.
Publicado: (2008)

Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: An immunohistochemical study
por: Karidis, Nikolaos P., et al.
Publicado: (2011)

Study of bone marrow microstructure in healthy young adults using intravoxel incoherent motion diffusion-weighted MRI
por: Wu, Wenqi, et al.
Publicado: (2022)

Synthetic MRI, multiplexed sensitivity encoding, and BI-RADS for benign and malignant breast cancer discrimination
por: Liu, Jinrui, et al.
Publicado: (2023)

Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules
por: Saleh, Husain A, et al.
Publicado: (2010)

An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions
por: Zhang, Renzhi, et al.
Publicado: (2022)

Relative time-intensity curve: a new method to differentiate benign and malignant lesions on breast MRI
por: Sherif, H, et al.
Publicado: (2014)

Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China
por: Fan, Wei Xiong, et al.
Publicado: (2018)

Diffusion-Weighted Mri of Postmenopausal Women with Vaginal Bleeding and Endometrial Thickening: Differentiation of Benign and Malignant Lesions
por: Çavuşoğlu, Mehtap, et al.
Publicado: (2016)

Multi-modality radiomics nomogram based on DCE-MRI and ultrasound images for benign and malignant breast lesion classification
por: Liu, Xinmiao, et al.
Publicado: (2022)

An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease.
por: McClinton, S., et al.
Publicado: (1990)

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
por: Howarth, D. J., et al.
Publicado: (1997)

Value of Intra-Perinodular Textural Transition Features from MRI in Distinguishing Between Benign and Malignant Testicular Lesions
por: Zhang, Peipei, et al.
Publicado: (2021)

Radiofrequency for benign and malign thyroid lesions
por: Rangel, Leonardo, et al.
Publicado: (2020)

Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: An immunohistochemical study
por: Giaginis, Constantinos, et al.
Publicado: (2011)

Sonoelastography for differential diagnosis between malignant and benign parotid lesions: a meta-analysis
por: Zhang, Yun-Fei, et al.
Publicado: (2018)

Role of morphometry in the cytological differentiation of benign and malignant thyroid lesions
por: Khatri, Pallavi, et al.
Publicado: (2017)

A dynamic lesion model for differentiation of malignant and benign pathologies
por: Cao, Weiguo, et al.
Publicado: (2021)

Differentiating malignant and benign eyelid lesions using deep learning
por: Lee, Min Joung, et al.
Publicado: (2023)

Comparative immunohistochemical analysis of Beclin-1 & MDM-2 in benign & malignant ameloblastomas
por: Elbarrawy, MA
Publicado: (2015)

Effectivity of combined diffusion-weighted imaging and contrast-enhanced MRI in malignant and benign breast lesions
por: Yadav, Pratiksha, et al.
Publicado: (2018)

Discrimination of Malignant and Benign Breast Lesions Using Quantitative Multiparametric MRI: A Preliminary Study
por: Li, Kurt, et al.
Publicado: (2020)

Application of Diffusion Weighted Imaging Techniques for Differentiating Benign and Malignant Breast Lesions
por: He, Muzhen, et al.
Publicado: (2021)

Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study
por: Yang, Lu, et al.
Publicado: (2023)

Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia
por: Bian, Wenjin, et al.
Publicado: (2023)

Comparison of Abbreviated MRI and Full Diagnostic MRI in Distinguishing between Benign and Malignant Lesions Detected by Breast MRI: A Multireader Study
por: Kim, Eun Sil, et al.
Publicado: (2021)

Imaging Findings of Solitary Spinal Bony Lesions and the Differential Diagnosis of Benign and Malignant Lesions
por: Kim, Young Soo, et al.
Publicado: (2012)

Role of metallothioneins in benign and malignant thyroid lesions
por: Pula, Bartosz, et al.
Publicado: (2012)

Diagnostic Snapshot: Aggressive Malignancy or Benign Lesion?
por: Goforth, Paige M.
Publicado: (2014)

Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.
por: Luqmani, Y. A., et al.
Publicado: (1993)

Evaluation of Microvessel Density of Hepatocellular Carcinoma and Comparison with Benign Lesions of Liver: An Immunohistochemical Study
por: Amoueian, S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0u38qabjsdpeilbi10b1gu89da